禾荣癌症靶向放射治疗设备问世

Reported about 1 year ago

禾荣科技宣布取得台湾TFDA核准的AB-BNCT设备醫療器材许可证，成为首台国产癌症靶向放射治疗设备。该技术结合標靶治療和放射治疗优点，使治疗过程更精准有效。禾荣已启动IPO计划，目标今年底登上興櫃，明年以科技事业申请上市。未来将在国内外大型医院布局，助力海外市场拓展。

You may also interested in these wikis

2 Overlooked Growth Stocks Ready to Shine

US–EU Trade Agreement: Key Highlights

TFI Reports Decline in Metrics but High Margins in 2Q 2024

Werner's Quarterly Report Shows Positive Impact from Nuclear Verdict Victory

Billionaire Paul Singer Increases Stake in Equinix: Is It Time to Invest?

Zubin Appoo Appointed as New CEO of WiseTech Global

Brown & Brown Sees Profit Growth Driven by Increased Commissions and Fees

US and EU Reach Trade Deal Amid Mixed Business Reactions

UBS Increases Price Target for Lam Research Corporation (LRCX) to $120

Spotify Stock Drops After Q2 Loss and Dismal Outlook

Back to all Wikis